Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans

Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.

Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.

epidemiology
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Kerry Grens | Apr 7, 2021
A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Jef Akst | Mar 24, 2021
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.
Frontiers Removes Controversial Ivermectin Paper Pre-Publication
Frontiers Removes Controversial Ivermectin Paper Pre-Publication
Catherine Offord | Mar 2, 2021
A review article containing contested claims about the tropical medicine drug as a COVID-19 treatment was listed as “provisionally accepted” on the journal’s website before being removed this week.
COVID-19 More Deadly with Blood than Solid Cancer: Study
COVID-19 More Deadly with Blood than Solid Cancer: Study
Marcus A. Banks | Feb 16, 2021
Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.
Second Person Dies in Latest Ebola Outbreak in DRC
Second Person Dies in Latest Ebola Outbreak in DRC
Catherine Offord | Feb 11, 2021
The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.
Antibody Spike Months After Ebola Infection Surprisingly Common
Antibody Spike Months After Ebola Infection Surprisingly Common
Catherine Offord | Jan 27, 2021
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
Special report
A Guide to Emerging SARS-CoV-2 Variants
A Guide to Emerging SARS-CoV-2 Variants
Katarina Zimmer | Jan 26, 2021
Scientists across the world are closely tracking the spread of mutations in the coronavirus and investigating whether they could render current vaccines less effective.
SARS-CoV-2 Isn’t Going Away, Experts Predict
SARS-CoV-2 Isn’t Going Away, Experts Predict
David Adam | Jan 25, 2021
As politicians try to schedule an end to the pandemic, scientists say the virus will stick around as an endemic disease similar to the common cold.
Record Drop in US Cancer Death Rate
Record Drop in US Cancer Death Rate
Asher Jones | Jan 13, 2021
From 2017 to 2018, cancer deaths dropped by 2.4 percent, the largest single-year improvement recorded in 70 years of American Cancer Society annual cancer reports.